Experimental model for proliferative vitreoretinopathy by intravitreal dispase: Limited by zonulolysis and cataract

Martina T. Kralinger, Gerhard F. Kieselbach, Monika Voigt, Brandy Hayden, Eleut Hernandez, Viviana Fernandez, Jean-Marie A Parel

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: The intravitreal injection of dispase has been shown to be a valuable method for induction of experimental PVR. The goal of the present study was to gain additional information about potential side effects associated with this method. Methods: Twenty-one pigmented rabbits received a single injection of dispase under topical anesthesia to one eye only, contralateral eyes served as untreated control. The animals were injected with doses from 0.045 to 0.065 units of dispase: 8 animals received 0.045 units, 9 animals 0.055 units and 4 animals 0.065 units. Results: Proliferative vitreoretinopathy occurred in 81% of the treated eyes. In 90% cataract formation was observed. Lens luxation was present in 47.3% of the cataract eyes. Conclusion: Intravitreal injection of dispase resulted in the reproducible induction of PVR in addition to cataract formation and lens luxation. Whether these effects may all be associated with a toxic reaction or whether the proliferative changes are solely triggered by endogenous reactions similar to the pathomechanism of human PVR and whether the cataract formation and the lens luxation may be avoided by changing the method of injection require further investigation.

Original languageEnglish
Pages (from-to)211-216
Number of pages6
JournalOphthalmologica
Volume220
Issue number4
DOIs
StatePublished - Jun 1 2006

Fingerprint

Proliferative Vitreoretinopathy
Cataract
Theoretical Models
Lenses
Intravitreal Injections
Injections
Poisons
Anesthesia
Rabbits
dispase

Keywords

  • Cataract
  • Dispase
  • Experimental model
  • Intravitreal injection
  • Proliferative vitreoretinopathy
  • Zonulolysis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Experimental model for proliferative vitreoretinopathy by intravitreal dispase : Limited by zonulolysis and cataract. / Kralinger, Martina T.; Kieselbach, Gerhard F.; Voigt, Monika; Hayden, Brandy; Hernandez, Eleut; Fernandez, Viviana; Parel, Jean-Marie A.

In: Ophthalmologica, Vol. 220, No. 4, 01.06.2006, p. 211-216.

Research output: Contribution to journalArticle

Kralinger, MT, Kieselbach, GF, Voigt, M, Hayden, B, Hernandez, E, Fernandez, V & Parel, J-MA 2006, 'Experimental model for proliferative vitreoretinopathy by intravitreal dispase: Limited by zonulolysis and cataract', Ophthalmologica, vol. 220, no. 4, pp. 211-216. https://doi.org/10.1159/000093073
Kralinger MT, Kieselbach GF, Voigt M, Hayden B, Hernandez E, Fernandez V et al. Experimental model for proliferative vitreoretinopathy by intravitreal dispase: Limited by zonulolysis and cataract. Ophthalmologica. 2006 Jun 1;220(4):211-216. https://doi.org/10.1159/000093073
Kralinger, Martina T. ; Kieselbach, Gerhard F. ; Voigt, Monika ; Hayden, Brandy ; Hernandez, Eleut ; Fernandez, Viviana ; Parel, Jean-Marie A. / Experimental model for proliferative vitreoretinopathy by intravitreal dispase : Limited by zonulolysis and cataract. In: Ophthalmologica. 2006 ; Vol. 220, No. 4. pp. 211-216.
@article{908c35ca4a1442aebb84a4bc769b9277,
title = "Experimental model for proliferative vitreoretinopathy by intravitreal dispase: Limited by zonulolysis and cataract",
abstract = "Background: The intravitreal injection of dispase has been shown to be a valuable method for induction of experimental PVR. The goal of the present study was to gain additional information about potential side effects associated with this method. Methods: Twenty-one pigmented rabbits received a single injection of dispase under topical anesthesia to one eye only, contralateral eyes served as untreated control. The animals were injected with doses from 0.045 to 0.065 units of dispase: 8 animals received 0.045 units, 9 animals 0.055 units and 4 animals 0.065 units. Results: Proliferative vitreoretinopathy occurred in 81{\%} of the treated eyes. In 90{\%} cataract formation was observed. Lens luxation was present in 47.3{\%} of the cataract eyes. Conclusion: Intravitreal injection of dispase resulted in the reproducible induction of PVR in addition to cataract formation and lens luxation. Whether these effects may all be associated with a toxic reaction or whether the proliferative changes are solely triggered by endogenous reactions similar to the pathomechanism of human PVR and whether the cataract formation and the lens luxation may be avoided by changing the method of injection require further investigation.",
keywords = "Cataract, Dispase, Experimental model, Intravitreal injection, Proliferative vitreoretinopathy, Zonulolysis",
author = "Kralinger, {Martina T.} and Kieselbach, {Gerhard F.} and Monika Voigt and Brandy Hayden and Eleut Hernandez and Viviana Fernandez and Parel, {Jean-Marie A}",
year = "2006",
month = "6",
day = "1",
doi = "10.1159/000093073",
language = "English",
volume = "220",
pages = "211--216",
journal = "Ophthalmologica",
issn = "0030-3755",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Experimental model for proliferative vitreoretinopathy by intravitreal dispase

T2 - Limited by zonulolysis and cataract

AU - Kralinger, Martina T.

AU - Kieselbach, Gerhard F.

AU - Voigt, Monika

AU - Hayden, Brandy

AU - Hernandez, Eleut

AU - Fernandez, Viviana

AU - Parel, Jean-Marie A

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Background: The intravitreal injection of dispase has been shown to be a valuable method for induction of experimental PVR. The goal of the present study was to gain additional information about potential side effects associated with this method. Methods: Twenty-one pigmented rabbits received a single injection of dispase under topical anesthesia to one eye only, contralateral eyes served as untreated control. The animals were injected with doses from 0.045 to 0.065 units of dispase: 8 animals received 0.045 units, 9 animals 0.055 units and 4 animals 0.065 units. Results: Proliferative vitreoretinopathy occurred in 81% of the treated eyes. In 90% cataract formation was observed. Lens luxation was present in 47.3% of the cataract eyes. Conclusion: Intravitreal injection of dispase resulted in the reproducible induction of PVR in addition to cataract formation and lens luxation. Whether these effects may all be associated with a toxic reaction or whether the proliferative changes are solely triggered by endogenous reactions similar to the pathomechanism of human PVR and whether the cataract formation and the lens luxation may be avoided by changing the method of injection require further investigation.

AB - Background: The intravitreal injection of dispase has been shown to be a valuable method for induction of experimental PVR. The goal of the present study was to gain additional information about potential side effects associated with this method. Methods: Twenty-one pigmented rabbits received a single injection of dispase under topical anesthesia to one eye only, contralateral eyes served as untreated control. The animals were injected with doses from 0.045 to 0.065 units of dispase: 8 animals received 0.045 units, 9 animals 0.055 units and 4 animals 0.065 units. Results: Proliferative vitreoretinopathy occurred in 81% of the treated eyes. In 90% cataract formation was observed. Lens luxation was present in 47.3% of the cataract eyes. Conclusion: Intravitreal injection of dispase resulted in the reproducible induction of PVR in addition to cataract formation and lens luxation. Whether these effects may all be associated with a toxic reaction or whether the proliferative changes are solely triggered by endogenous reactions similar to the pathomechanism of human PVR and whether the cataract formation and the lens luxation may be avoided by changing the method of injection require further investigation.

KW - Cataract

KW - Dispase

KW - Experimental model

KW - Intravitreal injection

KW - Proliferative vitreoretinopathy

KW - Zonulolysis

UR - http://www.scopus.com/inward/record.url?scp=33745436484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745436484&partnerID=8YFLogxK

U2 - 10.1159/000093073

DO - 10.1159/000093073

M3 - Article

C2 - 16785750

AN - SCOPUS:33745436484

VL - 220

SP - 211

EP - 216

JO - Ophthalmologica

JF - Ophthalmologica

SN - 0030-3755

IS - 4

ER -